Hypoxia imaging with the nitroimidazole 18F-FAZA PET tracer: A comparison with OxyLite, EPR oximetry and 19F-MRI relaxometry

被引:65
作者
Ly-Binh-An Tran
Bol, Anne [2 ]
Labar, Daniel [2 ]
Jordan, Benedicte
Magat, Julie
Mignion, Lionel
Gregoire, Vincent [2 ]
Gallez, Bernard [1 ]
机构
[1] Catholic Univ Louvain, Louvain Drug Res Inst, Biomed Magnet Resonance Grp REMA, B-1200 Brussels, Belgium
[2] Catholic Univ Louvain, Inst Expt & Clin Res, B-1200 Brussels, Belgium
关键词
Tumor hypoxia; F-18-FAZA; PET; EPR; MRI; OxyLite; ELECTRON-PARAMAGNETIC-RESONANCE; SQUAMOUS-CELL CARCINOMA; TUMOR OXYGENATION; IN-VIVO; RADIATION-THERAPY; ADVANCED CANCER; PO(2); HEAD; NECK; RADIOTHERAPY;
D O I
10.1016/j.radonc.2012.04.011
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and purpose: F-18-FAZA is a nitroimidazole PET tracer that can provide images of tumor hypoxia. However, it cannot provide absolute pO(2) values. To qualify F-18-FAZA PET, we compared PET images to pO(2) measured by OxyLite. EPR oximetry and F-19-MRI. Materials and methods: Male WAG/Rij rats grafted with rhabdomyosarcoma were used. Tumor oxygenation was modified by gas breathing (air or carbogen). The same day of PET acquisition, the pO(2) was measured in the same tumor either by OxyLite probes (measurement at 10 different sites), EPR oximetry using low frequency EPR or F-19-relaxometry using 15C5 on an 11.7 T MR system. Results: There was a good correlation between the results obtained by PET and EPR (R = 0.93). In the case of OxyLite, although a weaker correlation was observed (R = 0.55), the trend for two values to agree was still related to the inverse function theoretically predicted. For the comparison of F-18-FAZA PET and F-19-MRI, no change in T-1 was observed. Conclusions: A clear correlation between F-18-FAZA PET image intensities and tumor oxygenation was demonstrated, suggesting that F-18-FAZA PET is a promising imaging technique to guide cancer therapy. (C) 2012 Elsevier Ireland Ltd. All rights reserved. Radiotherapy and Oncology 105 (2012) 29-35
引用
收藏
页码:29 / 35
页数:7
相关论文
共 65 条
[41]   Hypoxic radiosensitization: Adored and ignored [J].
Overgaard, Jens .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (26) :4066-4074
[43]   Novel particulate spin probe for targeted determination of oxygen in cells and tissues [J].
Pandian, RP ;
Parinandi, NL ;
Ilangovan, G ;
Zweier, JL ;
Kuppusamy, P .
FREE RADICAL BIOLOGY AND MEDICINE, 2003, 35 (09) :1138-1148
[44]  
Piert M, 2005, J NUCL MED, V46, P106
[45]   Initial results of hypoxia imaging using 1-α-D-(5-deoxy-5-[18F]-fluoroarabinofuranosyl)-2-nitroimidazole (18F-FAZA) [J].
Postema, Ernst J. ;
McEwan, Alexander J. B. ;
Riauka, Terence A. ;
Kumar, Piyush ;
Richmond, Dacia A. ;
Abrams, Douglas N. ;
Wiebe, Leonard I. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 (10) :1565-1573
[46]   Hypoxia imaging-directed radiation treatment planning [J].
Rajendran, J. G. ;
Hendrickson, K. R. G. ;
Spence, A. M. ;
Muzi, M. ;
Krohn, K. A. ;
Mankoff, D. A. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 (Suppl 1) :S44-S53
[47]   Preparation of the hypoxia imaging PET tracer [18F]FAZA:: reaction parameters and automation [J].
Reischl, G ;
Ehrlichmann, W ;
Bieg, C ;
Solbach, C ;
Kumar, P ;
Wiebe, LI ;
Machulla, H .
APPLIED RADIATION AND ISOTOPES, 2005, 62 (06) :897-901
[48]  
Reischl G, 2006, J NUCL MED, V47, p91P
[49]  
REISCHL G, 2007, J NUCL MED S2, V48, pP325
[50]  
Reischl G, 2007, J PHARM PHARM SCI, V10, P203